Vermillion & White Wealth Management Group’s AbbVie ABBV Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-432	Closed	-$98.9K	–	68
2025 Q4	$98.9K	Hold	432	–	–	0.05%	99
2025 Q3	$99.9K	Buy	432 +252	+140%	+$51.3K	0.06%	101
2025 Q2	$33.4K	Buy	180 +2	+1%	+$372	0.02%	176
2025 Q1	$37.4K	Buy	178 +1	+0.6%	+$194	0.03%	149
2024 Q4	$31.4K	Buy	177 +2	+1%	+$368	0.02%	163
2024 Q3	$34.6K	Buy	175 +1	+0.6%	+$187	0.03%	156
2024 Q2	$29.8K	Buy	174 +2	+1%	+$331	0.02%	164
2024 Q1	$31.4K	Buy	172 +2	+1%	+$345	0.03%	148
2023 Q4	$26.5K	Buy	+170	New	+$24.8K	0.03%	129

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vermillion & White Wealth Management Group's ABBV Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 432 shares — an estimated $98.9K sold.

Vermillion & White Wealth Management Group first reported a position in ABBV in Q4 2023 and held it in 9 quarters. The position peaked at $99.9K in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Vermillion & White Wealth Management Group reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Vermillion & White Wealth Management Group sold 432 AbbVie shares in Q1 2026, an estimated $98.9K.
Vermillion & White Wealth Management Group first reported a position in AbbVie in Q4 2023 and held it in 9 quarters.
Vermillion & White Wealth Management Group's AbbVie position peaked at $99.9K in Q3 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.